View in EDS

Lower Risk of Type 2 Diabetes Mellitus With PCSK9 Inhibitors Compared With Other Lipid-Lowering Agents Among Patients With Hyperlipidaemia.

Saved in:
Bibliographic Details
Title: Lower Risk of Type 2 Diabetes Mellitus With PCSK9 Inhibitors Compared With Other Lipid-Lowering Agents Among Patients With Hyperlipidaemia.
Authors: Lin JL; Division of Endocrinology and Metabolism, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan.; Department of Medicine, MacKay Medical University, New Taipei City, Taiwan., Hsu C; Department of Medicine, Monmouth Medical Center, Robert Wood Johnson/Barnabas Health Care System, Long Branch, New Jersey, USA., Lo SW; Department of Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA., Nigam N; Department of Medicine, Monmouth Medical Center, Robert Wood Johnson/Barnabas Health Care System, Long Branch, New Jersey, USA., Shenoi M; Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA., Tu YF; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Bhanderi H; Department of Medicine, Monmouth Medical Center, Robert Wood Johnson/Barnabas Health Care System, Long Branch, New Jersey, USA., Chen CC; Department of Pathology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan.; Department of Cosmetic Science, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.; Ph.D. Program in Translational Medicine, Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan.; Department of Biotechnology and Bioindustry Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan., Su YJ; Orthopedics Department, Chi-Mei Medical Center, Tainan, Taiwan., Chang HC; Evidence-Based Medicine Center, Chung Shan Medical University Hospital, Taichung, Taiwan.; Library, Chung Shan Medical University Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan., Gau SY; Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Medical Education, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan.; Department and Graduate Institute of Business Administration, National Taiwan University, Taipei, Taiwan.
Source: Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2026 Jul; Vol. 42 (5), pp. e70188.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883450 Publication Model: Print Cited Medium: Internet ISSN: 1520-7560 (Electronic) Linking ISSN: 15207552 NLM ISO Abbreviation: Diabetes Metab Res Rev Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42274293
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Lower Risk of Type 2 Diabetes Mellitus With PCSK9 Inhibitors Compared With Other Lipid-Lowering Agents Among Patients With Hyperlipidaemia.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lin+JL%22">Lin JL</searchLink>; Division of Endocrinology and Metabolism, Department of Internal Medicine, MacKay Memorial Hospital, Taipei, Taiwan.; Department of Medicine, MacKay Medical University, New Taipei City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hsu+C%22">Hsu C</searchLink>; Department of Medicine, Monmouth Medical Center, Robert Wood Johnson/Barnabas Health Care System, Long Branch, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Lo+SW%22">Lo SW</searchLink>; Department of Medicine, Cleveland Clinic Foundation, Cleveland, Ohio, USA.<br /><searchLink fieldCode="AU" term="%22Nigam+N%22">Nigam N</searchLink>; Department of Medicine, Monmouth Medical Center, Robert Wood Johnson/Barnabas Health Care System, Long Branch, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Shenoi+M%22">Shenoi M</searchLink>; Department of Internal Medicine, Rochester General Hospital, Rochester, New York, USA.<br /><searchLink fieldCode="AU" term="%22Tu+YF%22">Tu YF</searchLink>; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Bhanderi+H%22">Bhanderi H</searchLink>; Department of Medicine, Monmouth Medical Center, Robert Wood Johnson/Barnabas Health Care System, Long Branch, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Chen+CC%22">Chen CC</searchLink>; Department of Pathology, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan.; Department of Cosmetic Science, Chia Nan University of Pharmacy and Science, Tainan, Taiwan.; Ph.D. Program in Translational Medicine, Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan.; Department of Biotechnology and Bioindustry Sciences, College of Bioscience and Biotechnology, National Cheng Kung University, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Su+YJ%22">Su YJ</searchLink>; Orthopedics Department, Chi-Mei Medical Center, Tainan, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chang+HC%22">Chang HC</searchLink>; Evidence-Based Medicine Center, Chung Shan Medical University Hospital, Taichung, Taiwan.; Library, Chung Shan Medical University Hospital, Taichung, Taiwan.; School of Medicine, Chung Shan Medical University, Taichung, Taiwan.<br /><searchLink fieldCode="AU" term="%22Gau+SY%22">Gau SY</searchLink>; Institute of Allergology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; Department of Medical Education, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi City, Taiwan.; Department and Graduate Institute of Business Administration, National Taiwan University, Taipei, Taiwan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100883450%22">Diabetes/metabolism research and reviews</searchLink> [Diabetes Metab Res Rev] 2026 Jul; Vol. 42 (5), pp. e70188.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Comparative Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100883450 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1520-7560 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2215207552%22">15207552 </searchLink><i>NLM ISO Abbreviation: </i>Diabetes Metab Res Rev <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42274293
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/dmrr.70188
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70188
    Titles:
      – TitleFull: Lower Risk of Type 2 Diabetes Mellitus With PCSK9 Inhibitors Compared With Other Lipid-Lowering Agents Among Patients With Hyperlipidaemia.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lin JL
      – PersonEntity:
          Name:
            NameFull: Hsu C
      – PersonEntity:
          Name:
            NameFull: Lo SW
      – PersonEntity:
          Name:
            NameFull: Nigam N
      – PersonEntity:
          Name:
            NameFull: Shenoi M
      – PersonEntity:
          Name:
            NameFull: Tu YF
      – PersonEntity:
          Name:
            NameFull: Bhanderi H
      – PersonEntity:
          Name:
            NameFull: Chen CC
      – PersonEntity:
          Name:
            NameFull: Su YJ
      – PersonEntity:
          Name:
            NameFull: Chang HC
      – PersonEntity:
          Name:
            NameFull: Gau SY
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2026 Jul
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1520-7560
          Numbering:
            – Type: volume
              Value: 42
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Diabetes/metabolism research and reviews
              Type: main
ResultId 1